Home › Compare › CSWYF vs GBDC

CSWYF vs GBDC: Dividend Comparison 2026

CSWYF yields 6.44% · GBDC yields 11.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CSWYF wins by $26973.42M in total portfolio value· pulled ahead in Year 3
10 years
CSWYF
CSWYF
● Live price
6.44%
Share price
$1.00
Annual div
$0.06
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26994.20M
Annual income
$26,212,634,649.46
Full CSWYF calculator →
GBDC
GBDC
● Live price
11.85%
Share price
$12.66
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.78M
Annual income
$16,389,263.41
Full GBDC calculator →

Portfolio growth — CSWYF vs GBDC

📍 CSWYF pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCSWYFGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CSWYF + GBDC cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CSWYF pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CSWYF
Annual income on $10K today (after 15% tax)
$547.65/yr
After 10yr DRIP, annual income (after tax)
$22,280,739,452.04/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.11/yr
After 10yr DRIP, annual income (after tax)
$13,930,873.90/yr
At 15% tax rate, CSWYF beats the other by $22,266,808,578.14/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CSWYF + GBDC for your $10,000?

CSWYF: 50%GBDC: 50%
100% GBDC50/50100% CSWYF
Portfolio after 10yr
$13507.49M
Annual income
$13,114,511,956.43/yr
Blended yield
97.09%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

CSWYF
No analyst data
Altman Z
2.7
Piotroski
5/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.6% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CSWYF buys
0
GBDC buys
0
No recent congressional trades found for CSWYF or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCSWYFGBDC
Forward yield6.44%11.85% ✓
Annual dividend / share$0.06$1.50 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100% ✓51.1%
Portfolio after 10y$26994.20M ✓$20.78M
Annual income after 10y$26,212,634,649.46 ✓$16,389,263.41
Total dividends collected$26940.26M ✓$20.36M
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: CSWYF vs GBDC ($10,000, DRIP)

YearCSWYF PortfolioCSWYF Income/yrGBDC PortfolioGBDC Income/yrGap
1$11,989$1,288.59$12,490$1,790.28$501.00 → GBDC
2$15,715$2,887.54$16,522$3,157.73$807.00 → GBDC
3← crossover$23,890$7,075.04$23,578$5,898.68+$312.00 → CSWYF
4$45,666$20,103.69$37,115$11,886.75+$8.6K → CSWYF
5$120,691$71,828.26$66,136$26,423.57+$54.6K → CSWYF
6$483,970$354,830.11$137,257$66,491.44+$346.7K → CSWYF
7$3,177,402$2,659,553.89$341,734$194,868.54+$2.84M → CSWYF
8$36,036,712$32,636,892.62$1,050,788$685,133.02+$34.99M → CSWYF
9$730,434,964$691,875,682.02$4,099,314$2,974,971.01+$726.34M → CSWYF
10$26,994,200,061$26,212,634,649.46$20,775,530$16,389,263.41+$26973.42M → CSWYF

CSWYF vs GBDC: Complete Analysis 2026

CSWYF — Stock

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong. The company offers modern Chinese medicines in the form of soft capsules, granules, and injections, as well as TCM Formula Granules in various therapeutic areas, including cardio-cerebrovascular, anti-viral, orthopedics, pediatrics, gynecology, and gastroenterology. It also trades in agricultural products. The company was incorporated in 2004 and is headquartered in Shijiazhuang, the People's Republic of China. China Shineway Pharmaceutical Group Limited is a subsidiary of Forway Investment Limited.

Full CSWYF Calculator →

GBDC — BDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this CSWYF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CSWYF vs SCHDCSWYF vs JEPICSWYF vs OCSWYF vs KOCSWYF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.